1. Home
  2. AFYA vs TARS Comparison

AFYA vs TARS Comparison

Compare AFYA & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFYA
  • TARS
  • Stock Information
  • Founded
  • AFYA 1999
  • TARS 2016
  • Country
  • AFYA Brazil
  • TARS United States
  • Employees
  • AFYA N/A
  • TARS N/A
  • Industry
  • AFYA Other Consumer Services
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • AFYA Real Estate
  • TARS Health Care
  • Exchange
  • AFYA Nasdaq
  • TARS Nasdaq
  • Market Cap
  • AFYA 1.6B
  • TARS 1.7B
  • IPO Year
  • AFYA 2019
  • TARS 2020
  • Fundamental
  • Price
  • AFYA $15.44
  • TARS $40.99
  • Analyst Decision
  • AFYA Sell
  • TARS Strong Buy
  • Analyst Count
  • AFYA 5
  • TARS 7
  • Target Price
  • AFYA $17.60
  • TARS $67.14
  • AVG Volume (30 Days)
  • AFYA 105.6K
  • TARS 608.7K
  • Earning Date
  • AFYA 08-15-2025
  • TARS 08-07-2025
  • Dividend Yield
  • AFYA 1.57%
  • TARS N/A
  • EPS Growth
  • AFYA 41.32
  • TARS N/A
  • EPS
  • AFYA 1.31
  • TARS N/A
  • Revenue
  • AFYA $599,363,389.00
  • TARS $233,674,000.00
  • Revenue This Year
  • AFYA $15.52
  • TARS $122.94
  • Revenue Next Year
  • AFYA $8.72
  • TARS $44.14
  • P/E Ratio
  • AFYA $11.95
  • TARS N/A
  • Revenue Growth
  • AFYA 15.70
  • TARS 449.03
  • 52 Week Low
  • AFYA $14.52
  • TARS $20.08
  • 52 Week High
  • AFYA $19.90
  • TARS $57.28
  • Technical
  • Relative Strength Index (RSI)
  • AFYA 24.37
  • TARS 45.61
  • Support Level
  • AFYA $17.33
  • TARS $39.11
  • Resistance Level
  • AFYA $18.16
  • TARS $41.72
  • Average True Range (ATR)
  • AFYA 0.43
  • TARS 1.48
  • MACD
  • AFYA -0.21
  • TARS 0.13
  • Stochastic Oscillator
  • AFYA 3.67
  • TARS 50.36

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: